Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Ezra Koh

Vascular Surgery Houston, TX Medical Doctor

NPI 1639669872 CMS profile 11426761

6400 Fannin St Ste 2850, Houston, TX 77030

Open in the dashboard

General payments

$7,162

67 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ezra Koh of Houston, TX is reported in the CMS Open Payments database as having received $7,162 across 67 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 59th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,201 30
2024 General $1,656 19
2023 General $1,041 8
2022 General $1,264 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ezra Koh
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Ezra Koh were reported at $3,201. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Ezra Koh Vascular Surgery median Middle half National median
2019 $0 $796 $226–$2,363 $163
2020 $0 $348 $118–$1,110 $114
2021 $0 $471 $158–$1,421 $132
2022 $1,264 $725 $222–$2,183 $149
2023 $1,041 $836 $257–$2,440 $160
2024 $1,656 $909 $252–$2,619 $164
2025 $3,201 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Medtronic, Inc. $2,186 16 payments
  2. Silk Road Medical, Inc. $1,348 11 payments
  3. Davol Inc. $619 5 payments
  4. AngioDynamics, Inc. $511 4 payments
  5. Boston Scientific Corporation $467 3 payments
  6. W. L. Gore & Associates, Inc. $442 6 payments
  7. Terumo Medical Corporation $343 3 payments
  8. Bolton Medical Inc $342 4 payments
  9. Abiomed $210 2 payments
  10. Atricure, Inc. $145 1 payment
  11. Other $549 12 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $6,050 65 payments
  2. Grant $1,000 1 payment
  3. Education $112 1 payment
Products named General payments · program years 2022–2025
  1. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $1,348 11 payments
  2. ENROUTE Transcarotid Stent $1,348 11 payments
  3. ENDURANT IIS $1,050 14 payments
  4. ALPHAVAC $377 3 payments
  5. Progel Applicator Spray Tips $312 2 payments
  6. GLIDESHEATH SLENDER $253 2 payments
  7. GORE VIABAHN VBX Balloon Expandable Endo $247 2 payments
  8. TREO ABDOMINAL STENT-GRAFT SYSTEM $233 2 payments
  9. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $201 3 payments
  10. ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter $201 3 payments
  11. Other $2,770 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

67 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record